OA
Oaktree Acquisition Corp. III Life Sciences Unit
OACCU · NASDAQ
$10.89 -0.37% (-$0.04)
1M -0.37%
Market Cap $267.4M
P/E Ratio 39.59x
Div. Yield -
ROE 3.46%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
44 /100
Fair P/B 1.35x
P/E 39.59x
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
37 /100
Average Asset turnover 0.00x
ROE 3.46%
ROA 3.27%
Debt
41 /100
Moderate Current ratio 0.73x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
50 /100
Moderate Beta -0.03x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OACCU
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Zaid Pardesi
Employees
3
Headquarters
Los Angeles